Dr. Gehlert et al., CHARACTERIZATION OF THE PEPTIDE BINDING REQUIREMENTS FOR THE CLONED HUMAN PANCREATIC POLYPEPTIDE-PREFERRING RECEPTOR, Molecular pharmacology, 50(1), 1996, pp. 112-118
Traditionally, neuropeptide Y (NPY) receptors have been divided into Y
1 and Y2 subtypes based on peptide pharmacology and synaptic localizat
ion. Other receptor subtypes have been proposed based on preferences f
or NPY, peptide YY (PYY), or pancreatic polypeptide (PP). Recently, we
discovered a novel human member of this receptor family exhibiting hi
gh affinity for PP and PW. in the current study, we expressed a DNA cl
one encoding this human PP-preferring receptor [hPP1 (or Y4)] in Chine
se hamster ovary cells and performed a peptide structure-activity stud
y. [I-125]pPYY bound to homogenates of hPP1-Chinese hamster ovary cell
s with a K-d of 0.064 +/- 0.006 nM and a B-max of 244 +/- 12 fmol/mg p
rotein. Human PP inhibited binding with a K-i of 0.023 nM, whereas hum
an PW (K-i = 0.31 nM) and human NPY (K-i = 12 nM) were significantly l
ess potent. Rat, porcine, and bovine PP inhibited binding with similar
affinities to human PP, whereas avian PP was substantially less poten
t (K-i = 1 nM). Deletion of the first four amino acids reduced the aff
inity of bovine PP to 1 nu. Carboxyl-terminal fragments of NPY and PW
also had reduced potency compared with the native peptides. In additio
n, deletion of Tyr36-amide produced a substantial reduction in affinit
y. Pro34-substituted NPY and PW had modestly increased affinity compar
ed with the native peptides, although Gln34-bPP had similar affinity c
ompared with bovine PP, The carboxyl-terminally derived Y1 antagonist
1229U91 was a very potent (K-i = 0.042 nM) inhibitor of binding to hPP
1. Thus, the carboxyl-terminal region of PP seems to be the most impor
tant part of the peptide for high affinity binding to hPP1. A few key
residues (amino acids 2 and 3) in the amino-terminal region of PP cont
ribute to the high affinity of the native peptide. Thus, features requ
ired for peptide recognition by the hPP1 receptor seem to be distinct
from the Y1 and Y2 receptor.